Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Vigabatrin-Induced Encephalopathy in a 5.5-Month-Old Girl with Infantile Spasms due to Tuberous Sclerosis.

Klinaki E, Argyri I, Amountza G, Ioannidou G, Maritsi D, Garoufi A, Vartzelis G.

Case Rep Pediatr. 2019 Aug 25;2019:7249237. doi: 10.1155/2019/7249237. eCollection 2019.

2.

Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis.

Vartzelis G, Maritsi D, Nikolaidou M, Garoufi A, Kilidireas C.

Case Rep Pediatr. 2019 Jul 21;2019:8731613. doi: 10.1155/2019/8731613. eCollection 2019.

3.

Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.

Attilakos A, Dinopoulos A, Tsirouda M, Paschalidou M, Prasouli A, Stamati A, Parasxou N, Garoufi A.

Epilepsy Res. 2019 Sep;155:106162. doi: 10.1016/j.eplepsyres.2019.106162. Epub 2019 Jul 4.

PMID:
31301589
4.

Monitoring of biochemical parameters and coagulation tests in children with epilepsy treated with levetiracetam monotherapy.

Attilakos A, Dinopoulos A, Paschalidou M, Tsirouda M, Garoufi A.

Childs Nerv Syst. 2019 May 31. doi: 10.1007/s00381-019-04225-w. [Epub ahead of print] No abstract available.

PMID:
31152218
5.

Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study.

Attilakos A, Paschalidou M, Garoufi A, Tsirouda M, Papadopoulou A, Karalexi M, Dinopoulos A.

J Clin Neurol. 2019 Apr;15(2):149-151. doi: 10.3988/jcn.2019.15.2.149.

6.

Corrigendum to "Vitamin D status in children with epilepsy treated with levetiracetam monotherapy", [Epilepsy Res. 148 (2018) 116].

Attilakos A, Tsirouda M, Dinopoulos A, Garoufi A.

Epilepsy Res. 2019 Jan;149:123. doi: 10.1016/j.eplepsyres.2018.11.005. Epub 2018 Nov 22. No abstract available.

PMID:
30471807
7.

Vitamin D status in children with epilepsy treated with levetiracetam monotherapy.

Attilakos A, Tsirouda M, Dinopoulos A, Prasouli A, Garoufi A.

Epilepsy Res. 2018 Dec;148:116. doi: 10.1016/j.eplepsyres.2018.09.003. No abstract available. Erratum in: Epilepsy Res. 2019 Jan;149:123.

PMID:
30409460
8.

Effect of Levetiracetam Monotherapy on Liver Enzymes and Creatine Kinase Concentrations in Children with Epilepsy: A Prospective Study.

Attilakos A, Dinopoulos A, Paschalidou M, Tsirouda M, Prasouli A, Siafakas N, Garoufi A.

J Clin Neurol. 2018 Oct;14(4):594-595. doi: 10.3988/jcn.2018.14.4.594. No abstract available.

9.

Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Rizos CV, Elisaf MS, Skoumas I, Tziomalos K, Kotsis V, Rallidis L, Garoufi A, Athyros VG, Skalidis E, Kolovou G, Koutagiar I, Papagianni M, Antza C, Katsiki N, Ganotakis E, Liberopoulos EN.

Atherosclerosis. 2018 Oct;277:308-313. doi: 10.1016/j.atherosclerosis.2018.08.017.

PMID:
30270064
10.

An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Rizos CV, Athyros V, Bilianou E, Chrousos G, Garoufi A, Kolovou G, Kotsis V, Rallidis L, Skalidis E, Skoumas I, Tziomalos K, Liberopoulos EN.

Hormones (Athens). 2017 Jul;16(3):306-312. doi: 10.1007/BF03401525. Epub 2017 Nov 30.

PMID:
30091117
11.

Long-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study.

Attilakos A, Dinopoulos A, Paschalidou M, Tsirouda M, Karalexi M, Prasouli A, Garoufi A.

Epilepsy Res. 2018 Sep;145:160-162. doi: 10.1016/j.eplepsyres.2018.07.001. Epub 2018 Jul 6.

PMID:
30007241
12.

Serum sodium, potassium, and magnesium in children with epilepsy treated with levetiracetam monotherapy: A prospective study.

Attilakos A, Garoufi A, Paschalidou M, Tsirouda M, Siafakas N, Dinopoulos A.

CNS Neurosci Ther. 2018 Sep;24(9):846-847. doi: 10.1111/cns.12868. Epub 2018 Apr 23. No abstract available.

13.

Influence of hypercholesterolemia on serum antibodies against oxidized LDL in children and adolescents.

Garoufi A, Marmarinos A, Vraila VM, Dimou S, Pagoni A, Vorre S, Paraskakis I, Gourgiotis D.

Pediatr Int. 2018 Mar;60(3):287-293. doi: 10.1111/ped.13501. Epub 2018 Feb 26.

PMID:
29297961
14.

An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Rizos CV, Athyros V, Bilianou E, Chrousos G, Garoufi A, Kolovou G, Kotsis V, Rallidis L, Skalidis E, Skoumas I, Tziomalos K, Liberopoulos EN.

Hormones (Athens). 2017 Jul;16(3):200-204. doi: 10.14310/horm.2002.1749.

15.

Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.

Pisciotta L, Tozzi G, Travaglini L, Taurisano R, Lucchi T, Indolfi G, Papadia F, Di Rocco M, D'Antiga L, Crock P, Vora K, Nightingale S, Michelakakis H, Garoufi A, Lykopoulou L, Bertolini S, Calandra S.

Atherosclerosis. 2017 Oct;265:124-132. doi: 10.1016/j.atherosclerosis.2017.08.021. Epub 2017 Aug 26.

PMID:
28881270
16.

The impact of vitamin D supplementation on serum cathelicidin levels and the clinical course of atopic dermatitis in children.

Tsotra K, Garoufi A, Kossiva L, Gourgiotis D, Tsoukatou T, Katsantoni E, Stavropoulos P.

Minerva Pediatr. 2017 Jun 22. doi: 10.23736/S0026-4946.17.04910-6. [Epub ahead of print]

PMID:
28643993
17.

Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.

Garoufi A, Drapanioti S, Marmarinos A, Askiti V, Mitsioni AJ, Mila M, Grigoriadou G, Georgakopoulos D, Stefanidis CJ, Gourgiotis D.

BMC Nephrol. 2017 Mar 31;18(1):113. doi: 10.1186/s12882-017-0530-9.

18.

Associations between obesity, adverse behavioral patterns and cardiovascular risk factors among adolescent inhabitants of a Greek island.

Garoufi A, Grammatikos EE, Kollias A, Grammatikos E, Stergiou GS, Soldatou A.

J Pediatr Endocrinol Metab. 2017 Apr 1;30(4):445-454. doi: 10.1515/jpem-2016-0134.

PMID:
28315850
19.

Comparing calculated LDL-C with directly measured LDL-C in healthy and in dyslipidemic children.

Garoufi A, Drakatos A, Tsentidis C, Klinaki E, Paraskakis I, Marmarinos A, Gourgiotis D.

Clin Biochem. 2017 Jan;50(1-2):16-22. doi: 10.1016/j.clinbiochem.2016.05.026. Epub 2016 Nov 9.

PMID:
27836622
20.

The response to the inactivated Hepatitis A vaccine in children with autoinflammatory diseases: a prospective observational controlled study.

Maritsi DN, Vartzelis G, Kossiva L, Vougiouka O, Garoufi A.

Rheumatology (Oxford). 2016 Sep;55(9):1705-6. doi: 10.1093/rheumatology/kew239. Epub 2016 Jun 15. No abstract available.

PMID:
27313277
21.

Weight gain in children on oxcarbazepine monotherapy.

Garoufi A, Vartzelis G, Tsentidis C, Attilakos A, Koemtzidou E, Kossiva L, Katsarou E, Soldatou A.

Epilepsy Res. 2016 May;122:110-3. doi: 10.1016/j.eplepsyres.2016.03.004. Epub 2016 Mar 16.

PMID:
27010568
22.

Cystatin-C levels in healthy children and adolescents: Influence of age, gender, body mass index and blood pressure.

Marmarinos A, Garoufi A, Panagoulia A, Dimou S, Drakatos A, Paraskakis I, Gourgiotis D.

Clin Biochem. 2016 Jan;49(1-2):150-3. doi: 10.1016/j.clinbiochem.2015.10.012. Epub 2015 Oct 24.

PMID:
26506118
23.

Response to "No clinically significant lymphocyte count change in pediatric patients treated with levetiracetam".

Dinopoulos A, Attilakos A, Paschalidou M, Tsirouda M, Garoufi A, Siafakas N, Douros K.

Epilepsy Res. 2015 Aug;114:149-50. doi: 10.1016/j.eplepsyres.2015.05.003. Epub 2015 May 15. No abstract available.

PMID:
26024570
24.

Risk factors for elevated blood lead levels among children aged 6-36 months living in Greece.

Kapitsinou A, Soldatou A, Tsitsika A, Kossiva L, Tsentidis Ch, Nisianakis P, Theocharis S, Garoufi A.

Child Care Health Dev. 2015 Nov;41(6):1199-206. doi: 10.1111/cch.12254. Epub 2015 May 13.

PMID:
25968465
25.

Patients with eating disorders showed no signs of coeliac disease before and after nutritional intervention.

Kaltsa M, Garoufi A, Tsitsika A, Tsirogianni A, Papasteriades C, Kossiva L.

Acta Paediatr. 2015 Jul;104(7):e319-23. doi: 10.1111/apa.12985. Epub 2015 Mar 31.

PMID:
25721688
26.

Postinfectious Rhabdomyolysis in a 5-Year-Old Boy: When to Look a Little Deeper.

Garoufi A, Vartzelis G, Kossiva L, Katsarou E, Soldatou A.

Pediatr Emerg Care. 2015 Dec;31(12):851-2. doi: 10.1097/PEC.0000000000000308.

PMID:
25513977
27.

Plant sterols-enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study.

Garoufi A, Vorre S, Soldatou A, Tsentidis C, Kossiva L, Drakatos A, Marmarinos A, Gourgiotis D.

Ital J Pediatr. 2014 May 3;40:42. doi: 10.1186/1824-7288-40-42.

28.

Short-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: a prospective study.

Dinopoulos A, Attilakos A, Paschalidou M, Tsirouda M, Garoufi A, Moustaki M, Siafakas N, Papaevangelou V.

Epilepsy Res. 2014 May;108(4):820-3. doi: 10.1016/j.eplepsyres.2014.02.006. Epub 2014 Feb 19.

PMID:
24630047
29.

Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study.

Garoufi A, Koemtzidou E, Katsarou E, Dinopoulos A, Kalimeraki I, Fotinou A, Drakatos A, Attilakos A.

Eur J Neurol. 2014;21(1):118-23. doi: 10.1111/ene.12262. Epub 2013 Oct 1.

PMID:
24118208
30.

Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis.

Maritsi D, Vartzelis G, Soldatou A, Garoufi A, Spyridis N.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):969-73. Epub 2013 Jun 26.

PMID:
23806191
31.

Adiposity, blood pressure, and carotid intima-media thickness in greek adolescents.

Kollias A, Psilopatis I, Karagiaouri E, Glaraki M, Grammatikos E, Grammatikos EE, Garoufi A, Stergiou GS.

Obesity (Silver Spring). 2013 May;21(5):1013-7. doi: 10.1002/oby.20194.

32.

Acute renal failure in a child with thrombocytopenic purpura caused by acute Epstein-Barr virus infection after treatment with anti-D immunoglobulin.

Kossiva L, Kyriakou D, Mitsioni A, Garoufi A.

Pediatr Emerg Care. 2013 Jun;29(6):748-50. doi: 10.1097/PEC.0b013e318294f3a5.

PMID:
23736070
33.

A toddler with acute flaccid paralysis due to West Nile virus infection.

Soldatou A, Vartzelis G, Vorre S, Papa A, Voudris K, Garoufi A.

Pediatr Infect Dis J. 2013 Sep;32(9):1023-4. doi: 10.1097/INF.0b013e318292bf72.

PMID:
23538519
34.

Incomplete Kawasaki disease with intermittent fever and retropharyngeal inflammation.

Machaira M, Tsolia M, Constantopoulos I, Garoufi A, Kaltsa M, Radiotis A, Georgouli H.

Pediatr Infect Dis J. 2012 Apr;31(4):417-8. doi: 10.1097/INF.0b013e3182447a6c.

PMID:
22189530
35.

Hip monoarthritis in a child with cat-scratch disease: Rare manifestation.

Kossiva L, Vakaki M, Pasparakis D, Kallergi K, Karavanaki K, Garoufi A.

Pediatr Int. 2010 Aug;52(4):680-1. doi: 10.1111/j.1442-200X.2010.03152.x. No abstract available.

PMID:
20958885
36.

Too short stature, too many stigmata.

Kossiva L, Vartzelis G, Harisi M, Logotheti I, Garoufi A.

BMJ Case Rep. 2010 Nov 18;2010. pii: bcr0620103087. doi: 10.1136/bcr.06.2010.3087.

37.

Infant penile tuberculosis following circumcision.

Papaevangelou V, Vintila A, Papaparaskevas J, Kanavaki S, Garoufi A, Tsoukatou T, Tsolia M.

J Infect. 2009 Jan;58(1):83-5. doi: 10.1016/j.jinf.2008.11.011. Epub 2008 Dec 18.

PMID:
19100625
38.

Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.

Attilakos A, Katsarou E, Prassouli A, Mastroyianni S, Voudris K, Fotinou A, Garoufi A.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):32-4. doi: 10.1097/WNF.0B013E318166CBCD.

PMID:
18978499
39.

A rare thalassemic syndrome caused by interaction of Hb Adana [alpha59(E8)Gly-->Asp] with an alpha+-thalassemia deletion: clinical aspects in two cases.

Douna V, Papassotiriou I, Garoufi A, Georgouli E, Ladis V, Stamoulakatou A, Metaxotou-Mavrommati A, Kanavakis E, Traeger-Synodinos J.

Hemoglobin. 2008;32(4):361-9. doi: 10.1080/03630260802173890.

PMID:
18654886
40.

Transverse myelitis in 2 patients with Bartonella henselae infection (cat scratch disease).

Baylor P, Garoufi A, Karpathios T, Lutz J, Mogelof J, Moseley D.

Clin Infect Dis. 2007 Aug 15;45(4):e42-5. Epub 2007 Jul 5.

PMID:
17638185
41.

Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy.

Attilakos A, Voudris KA, Katsarou E, Prassouli A, Mastroyianni S, Garoufi A.

Clin Neuropharmacol. 2007 May-Jun;30(3):145-9.

PMID:
17545749
42.

Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship?

Attilakos A, Garoufi A, Voudris K, Mastroyianni S, Fotinou A, Papadimitriou DT, Gavalakis N, Prassouli A, Katsarou E.

Eur J Paediatr Neurol. 2007 Nov;11(6):358-61. Epub 2007 Apr 10.

PMID:
17428707
43.

Valproate-associated coagulopathies are frequent and variable in children.

Attilakos A, Katsarou E, Voudris K, Garoufi A.

Epilepsia. 2007 Jan;48(1):205-6. No abstract available.

44.

Acute acalculous cholecystitis as the initial presentation of primary Epstein-Barr virus infection.

Prassouli A, Panagiotou J, Vakaki M, Giannatou I, Atilakos A, Garoufi A, Papaevangelou V.

J Pediatr Surg. 2007 Jan;42(1):E11-3.

PMID:
17208530
45.

Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a rare cause of parainfectious rhabdomyolysis.

Mastroyianni SD, Garoufi A, Voudris K, Skardoutsou A, Stefanidis CJ, Katsarou E, Gooding R, Kalaydjieva L.

Eur J Pediatr. 2007 Jul;166(7):747-9. Epub 2006 Dec 30.

PMID:
17195938
46.

Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.

Attilakos A, Voudris KA, Garoufi A, Mastroyianni S, Dimou S, Prassouli A, Katsarou E.

Eur J Paediatr Neurol. 2006 Sep-Nov;10(5-6):237-40. Epub 2006 Oct 10.

PMID:
17035050
47.

Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy.

Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A.

Epilepsy Res. 2006 Oct;71(2-3):229-32. Epub 2006 Aug 4.

PMID:
16889940
48.

Homozygous MTHFR C677T gene mutation and recurrent stroke in an infant.

Garoufi AJ, Prassouli AA, Attilakos AV, Voudris KA, Katsarou ES.

Pediatr Neurol. 2006 Jul;35(1):49-51.

PMID:
16814086
49.

Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.

Voudris KA, Attilakos A, Katsarou E, Drakatos A, Dimou S, Mastroyianni S, Skardoutsou A, Prassouli A, Garoufi A.

Epilepsy Res. 2006 Aug;70(2-3):211-7. Epub 2006 Jun 15.

PMID:
16781120
50.

Serum total amylase, pancreatic amylase and lipase activities in epileptic children treated with sodium valproate monotherapy.

Voudris K, Attilakos A, Katsarou E, Mastroyianni S, Dimou S, Skardoutsou A, Prassouli A, Garoufi A.

Brain Dev. 2006 Oct;28(9):572-5. Epub 2006 May 26.

PMID:
16730152

Supplemental Content

Loading ...
Support Center